
Sign up to save your podcasts
Or


Solving the biopharma industry’s management crunch will require today’s leaders to open their networks, and provide more leadership opportunities and mentoring to rising leaders, says BioCentury Editor in Chief Simone Fishburn. On the third of five BioCentury This Week podcasts accompanying Back to School 2022, Fishburn and BioCentury’s editorial team discuss the group of employees who see the C-suite as their next step, why they want to get there and the impediments they must overcome. BioCentury’s editors also assess how VCs are building boards to guide first-time CEOs, and discuss concerns that the increase in compensation across the biopharma sector has gotten out of hand. Access all of BioCentury's Back to School content here.
https://www.biocentury.com/topics/back-to-school-auth
Reach us by sending a text
By BioCentury4.8
3131 ratings
Solving the biopharma industry’s management crunch will require today’s leaders to open their networks, and provide more leadership opportunities and mentoring to rising leaders, says BioCentury Editor in Chief Simone Fishburn. On the third of five BioCentury This Week podcasts accompanying Back to School 2022, Fishburn and BioCentury’s editorial team discuss the group of employees who see the C-suite as their next step, why they want to get there and the impediments they must overcome. BioCentury’s editors also assess how VCs are building boards to guide first-time CEOs, and discuss concerns that the increase in compensation across the biopharma sector has gotten out of hand. Access all of BioCentury's Back to School content here.
https://www.biocentury.com/topics/back-to-school-auth
Reach us by sending a text

962 Listeners

4,339 Listeners

399 Listeners

1,932 Listeners

423 Listeners

322 Listeners

6,092 Listeners

62 Listeners

9,927 Listeners

86 Listeners

18 Listeners

79 Listeners

51 Listeners

13 Listeners

12 Listeners